CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS)
Product revenue	$ 1,345.4	$ 1,381.1	$ 1,571.9
Service revenue	254.7	235.5	231.8
Other revenue	11.2	7.2	5.2
Total revenue	1,611.3	1,623.8	1,808.9
Cost of product revenue	714.2	774.2	896.0
Cost of service revenue	150.0	139.7	149.6
Cost of other revenue	4.6	1.3
Total cost of revenue	868.8	915.2	1,045.6
Gross profit	742.5	708.6	763.3
Operating expenses:
Selling, general and administrative	390.5	392.2	451.0
Research and development	149.0	145.7	174.2
Other charges, net	25.8	25.0	32.7
Total operating expenses	565.3	562.9	657.9
Operating income	177.2	145.7	105.4
Interest and other income (expense), net	0.4	(17.7)	(4.1)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	177.6	128.0	101.3
Income tax provision	23.1	23.1	41.7
Consolidated net income	154.5	104.9	59.6
Net income attributable to noncontrolling interest in consolidated subsidiaries	0.9	3.3	2.9
Net income attributable to Bruker Corporation	$ 153.6	$ 101.6	$ 56.7
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.95	$ 0.60	$ 0.34
Diluted (in dollars per share)	$ 0.95	$ 0.60	$ 0.33
Weighted average common shares outstanding:
Basic (in shares)	161.4	168.2	167.8
Diluted (in shares)	162.2	169.1	169.5
Consolidated net income	$ 154.5	$ 104.9	$ 59.6
Foreign currency translation adjustments	(27.6)	(63.8)	(131.7)
Pension liability adjustments (net of tax of $2.1 million, $2.1 million and $6.5 million, respectively)\	(4.4)	(9.6)	(22.6)
Net comprehensive income (loss)	122.5	31.5	(94.7)
Less: Comprehensive income attributable to noncontrolling interests	0.6	2.3	2.8
Comprehensive income (loss) attributable to Bruker Corporation	$ 121.9	$ 29.2	$ (97.5)
Dividend declared (in dollars per share)	$ 0.16